Skip to main content
. 2019 Feb 20;16:21. doi: 10.1186/s12985-019-1125-9

Fig. 5.

Fig. 5

Schematic showing that DMO-CAP inhibits influenza virus replication. DMO-CAP activated the MAPK pathways, thereby leading to Nrf2 expression and subsequent activation of HO-1 gene expression, as well as the up-regulation HO-1 activities host cellular type I IFN response with induction of ISGs expression, which finally leads to inhibition of influenza virus replication